Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sangamo Therapeutics (NQ: SGMO )

10.12 USD +0.35 (+3.58%)
Official Closing Price Updated: 4:44 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,103,000
Open 9.810
Bid (Size) 10.09 (5)
Ask (Size) 10.19 (10)
Prev. Close 9.770
Today's Range 9.810 - 10.13
52wk Range 4.810 - 13.20
Shares Outstanding 101,494,606
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences: 
From Business Wire News Releases
Sangamo Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported third quarter 2020 financial results and recent business highlights. 
From Business Wire News Releases

Performance

YTD
+23.26%
+23.26%
1 Month
-6.47%
-6.47%
3 Month
-6.73%
-6.73%
6 Month
-9.56%
-9.56%
1 Year
-6.30%
-6.30%

More News

Read More
Targeted Therapies for Glioblastoma Becoming Critical As Increasing Incidence of Brain Cancer Rises
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Targeted Therapies for Glioblastoma Becoming Critical As Increasing Incidence of Brain Cancer Rises
From PR Newswire
Sangamo Therapeutics Announces Third Quarter 2020 Conference Call and Webcast
From Business Wire News Releases
Cramer Advises Viewers On Ballard Power Systems, Blink Charging And More
Tags Small Cap Media PCG
From Benzinga
Look Under The Hood: PBE Has 22% Upside
Tags ETFs
From ETF Channel
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
Tags REGN Market News TEVA
From Motley Fool
Sangamo Therapeutics Sees IBD RS Rating Improve To 73
From Investor's Business Daily
Stock Upgrades: Sangamo Therapeutics Shows Rising Relative Strength
From Investor's Business Daily
First Week of December 18th Options Trading For Sangamo Therapeutics (SGMO)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.